Research Article: Promoting Intratumoral Drug Accumulation by Bio-Membrane Regulated Active Targeting for Tumor Photothermal Therapy
Introduction:
Traditional anti-cancer drugs exhibit a number of limitations in clinical practice, including off-target effects on normal tissues and inadequate accumulation at tumor sites. , Cancer nanomedicines have been specifically engineered to avoid the pharmacokinetic constraints associated with conventional drugs. Nanomedicines can selectively accumulate in tumor tissues through the enhanced permeability and retention (EPR) effect of tumors, which is a result of the abnormal leakage of blood vessels and inadequate…
Read more